Press Release Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026 Juniper Biosciences · Sep 15
Press Release Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS Remedy Plan Therapeutics · Sep 15
Press Release Connected Motorcycle Market worth $3.30 billion by 2033 | MarketsandMarkets™ MarketsandMarkets · Sep 15
Press Release Brunswick Corporation Demonstrates Strong Market Momentum at Cannes Yachting Festival 2026 Brunswick Corporation · Sep 15
Press Release Walden Biosciences Announces CMO Appointment and Upcoming Clinical Data for WAL0921 in Proteinuric Chronic Kidney Disease Walden Biosciences Securities Corporation · Sep 15
Press Release Roth Canada Expands Service Offering with Addition of Debt Capital Markets Roth Capital Partners · Sep 15
Press Release Lithium Argentina Announces Closing of $180M Strategic Investment from Ganfeng Lithium Argentina AG · Sep 15
Press Release Applitools Introduces Visual AI Guardrails to Prevent Quality Degradation and Reduce Review Burden in Agentic Coding Applitools · Sep 15
Press Release Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy Vera Therapeutics · Sep 15
Press Release Ingram Micro Outlines Long-term Strategy, Intelligence-led Transformation and Multi-year Financial Framework at Capital Markets Day Business Wire · Sep 15